I am not completely in agreement with you. Your statement was correct for Mike Withrow who screwed us all big time and is the main reason why Abattis is in the position it is in.
However, things have changed and the new board including CFO/COO Rene David has a plan in place to pull it off from this mess.
Hemp Water is the 1st product. They have other 4 products ready to be launched and are getting ready to be launched next.
Look at Lexaria corp (LXRP) or ENRT, they too had to forgave their pending license which I believe was even ahead of Abattis in the licensing stage and venture into ViPova Tea and V-Love lubricant business.
They too are doing everything possible to increase their own shareholder value. So is Abattis.
The main difference though is that Abattis has many revenue streams identified, although none has materialized in a big way, but they all have potential.
Biocell - 10 NPNs (in batches of 5 and 5) to be launched in coming 2 yrs.
3 license application including a CSL lab.
Vertical design grow systems
Biocubes
Extraction, Flash freeze , NO2 technology. Not sure how they all get used and applied, but they do have those IP.
Most of the companies in MMJ space has already diluted and have taken convertible debts to raise financing. Abattis is sensitive to shareholder interest and has gone the PP route.
I am not taking their side, but I think the new management and board is much more sensitive to existing long term shareholders and will do their best to pull it from this mess. Its not going to happen overnight, but I think this time next year, the price will be atleast 30-40 cents with revenue from 3 product of about 2-3 mil.
News 
Market Data 
Discover 
